Antipodes Partners’s American Express Global Business Travel GBTG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-32,085
Closed -$202K 122
2025
Q2
$202K Buy
32,085
+16,643
+108% +$107K 0.01% 63
2025
Q1
$112K Sell
15,442
-12,270
-44% -$103K ﹤0.01% 72
2024
Q4
$257K Buy
27,712
+14,828
+115% +$127K 0.01% 52
2024
Q3
$99.1K Sell
12,884
-5,252
-29% -$36.4K ﹤0.01% 62
2024
Q2
$120K Hold
18,136
﹤0.01% 55
2024
Q1
$109K Buy
+18,136
New +$106K ﹤0.01% 56

Other funds holding GBTG

Antipodes Partners's GBTG Position: Q3 2025 in Review

Antipodes Partners sold out of American Express Global Business Travel (GBTG) in Q3 2025, closing a stake of 32,085 shares — an estimated $202K sold.

Antipodes Partners first reported a position in GBTG in Q1 2024 and held it in 6 quarters. The position peaked at $257K in Q4 2024. 163 funds tracked by Wall St. Rank hold GBTG as of Q3 2025.

  • Antipodes Partners reported no remaining American Express Global Business Travel position as of Q3 2025 after selling out during the quarter.
  • Antipodes Partners sold 32,085 American Express Global Business Travel shares in Q3 2025, an estimated $202K.
  • Antipodes Partners first reported a position in American Express Global Business Travel in Q1 2024 and held it in 6 quarters.
  • Antipodes Partners's American Express Global Business Travel position peaked at $257K in Q4 2024.
  • 163 funds tracked by Wall St. Rank held American Express Global Business Travel as of Q3 2025.

Based on Antipodes Partners's 13F filing for Q3 2025, filed 10 Nov 2025.